Literature DB >> 10813787

Developmental expression of neurokinin-1 and neurokinin-3 receptors in the rat retina.

G Casini1, N C Brecha, L Bosco, D W Rickman.   

Abstract

Tachykinin (TK) peptides act on retinal neurons through neurokinin (NK) receptors. We examined the expression of neurokinin-1 (NK1; the substance P receptor), NK3 [the neurokinin B (NKB) receptor], and TK peptides in developing rat retinas. NK1 immunolabeling was found in newborn retinas in rare amacrine cells and in putative ganglion cells. At postnatal day 2 (PND 2), NK1 immunostaining was reduced greatly among ganglion cells, and it appeared in many amacrine cells and in fibers in the inner plexiform layer (IPL), with the highest density in laminae 1, 3, and 5. A similar pattern was found at PND 7. At PND 12, interplexiform NK1-immunoreactive (-IR) cells were detected, and NK1-IR fibers in the IPL were concentrated in lamina 2, similar to what was seen in adults. NK3 was expressed mainly by OFF-cone bipolar cells, and the developmental pattern of NK3 was compared with that of cone bipolar cells that were labeled with antibodies to recoverin. Immature recoverin-IR cone bipolar cells were seen at PND 2. NK3 immunolabeling was detected first in the outer plexiform layer and in sparse bipolar cell somata at PND 10, when recoverin-IR cone bipolar cells are nearly mature. By PND 15, both the NK3 immunostaining pattern and the recoverin immunostaining pattern were similar to the patterns seen in adults. TK immunoreactivity was present at PND 0 in amacrine cells and displaced amacrine cells. By PND 10, the morphologic maturation of TK-IR cells was complete. These findings indicate that, in early postnatal retinas, substance P may act on NK1 receptors, whereas NKB/NK3 interactions are unlikely, suggesting that there are different levels of importance for different TK peptides in the developing retina. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10813787

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  8 in total

1.  Inhibitory effect of certain neuropeptides on the proliferation of human retinal pigment epithelial cells.

Authors:  J Troger; S Sellemond; G Kieselbach; M Kralinger; E Schmid; B Teuchner; Q A Nguyen; E Schretter-Irschick; W Göttinger
Journal:  Br J Ophthalmol       Date:  2003-11       Impact factor: 4.638

2.  Retinal organization in the retinal degeneration 10 (rd10) mutant mouse: a morphological and ERG study.

Authors:  Claudia Gargini; Eva Terzibasi; Francesca Mazzoni; Enrica Strettoi
Journal:  J Comp Neurol       Date:  2007-01-10       Impact factor: 3.215

3.  Architecture of cannabinoid signaling in mouse retina.

Authors:  Sherry Shu-Jung Hu; Andy Arnold; Jacqueline M Hutchens; Josh Radicke; Benjamin F Cravatt; Jim Wager-Miller; Ken Mackie; Alex Straiker
Journal:  J Comp Neurol       Date:  2010-09-15       Impact factor: 3.215

4.  Mapping kainate activation of inner neurons in the rat retina.

Authors:  Lisa Nivison-Smith; Daniel Sun; Erica L Fletcher; Robert E Marc; Michael Kalloniatis
Journal:  J Comp Neurol       Date:  2013-08-01       Impact factor: 3.215

5.  Cholecystokinin-like immunoreactive amacrine cells in the rat retina.

Authors:  Sally I Firth; Carolina Varela; Pedro De la Villa; David W Marshak
Journal:  Vis Neurosci       Date:  2002 Jul-Aug       Impact factor: 3.241

6.  Immunocytochemical description of five bipolar cell types of the mouse retina.

Authors:  Silke Haverkamp; Krishna K Ghosh; Arlene A Hirano; Heinz Wässle
Journal:  J Comp Neurol       Date:  2003-01-20       Impact factor: 3.215

7.  Loss of Neuroligin3 specifically downregulates retinal GABAAα2 receptors without abolishing direction selectivity.

Authors:  Mrinalini Hoon; Vidhyasankar Krishnamoorthy; Tim Gollisch; Bjoern Falkenburger; Frederique Varoqueaux
Journal:  PLoS One       Date:  2017-07-14       Impact factor: 3.240

Review 8.  Relevance of Peptide Homeostasis in Metabolic Retinal Degenerative Disorders: Curative Potential in Genetically Modified Mice.

Authors:  Etelka Pöstyéni; Alma Ganczer; Andrea Kovács-Valasek; Robert Gabriel
Journal:  Front Pharmacol       Date:  2022-01-13       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.